Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
711 people get LH articles and Market Currents by email alert.
Get email alerts on LH »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Earnings Analysis: Quest Diagnostics Inc.CapitalCube • Thu, Oct 18, 2012
To learn more about Seeking Alpha Pro, click here.
-
Quest Lowers Outlook, Announces Cost-Reduction PlanZacks Investment Research • Thu, Jul 21, 2011 -
Laboratory Corporation of America: Earnings PreviewZacks Small-Cap • Wed, Feb 9, 2011 -
-
Laboratory Corp. Selloff Appears OverdoneNotable Calls • Thu, Aug 2, 2007
-
Lab Corp.'s Margins Miss Their MarkWilliam Trent • Wed, Jul 25, 2007
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Earnings Analysis: Quest Diagnostics Inc.CapitalCube • Thu, Oct 18, 2012
-
-
-
-
-
Insider Trading Report: Quest DiagnosticsInsider Monkey • Thu, Aug 9, 2012 -
-
Laboratory of America Holdings Q2 2010 Earnings Call TranscriptThu, Jul 22, 2010
-
Laboratory Corp. of America Holdings Q3 2009 Earnings Call TranscriptThu, Oct 22, 2009
-
at MarketWatch.com (Apr 16, 2013)
-
at CNBC.com (Oct 18, 2012)
-
at CNBC.com (Aug 27, 2012)
-
at CNBC.com (Aug 16, 2012)
-
at CNBC.com (Aug 1, 2012)
-
at CNBC.com (Aug 1, 2012)
-
at CNBC.com (Jul 21, 2012)
-
at MarketWatch.com (Jul 19, 2012)
-
at MarketWatch.com (Jul 19, 2012)
-
at CNBC.com (Jul 19, 2012)
-
at MarketWatch.com (Jul 19, 2012)
-
at MarketWatch.com (Jun 28, 2012)
-
at MarketWatch.com (Jun 5, 2012)
-
at CNBC.com (Jun 4, 2012)
-
at MarketWatch.com (Jun 4, 2012)
-
at CNBC.com (Apr 19, 2012)
-
at MarketWatch.com (Apr 19, 2012)
-
at MarketWatch.com (Feb 10, 2012)
-
at MarketWatch.com (Feb 10, 2012)
LH vs. ETF Alternatives
Company Description
Laboratory Corporation of America Holdings and its subsidiaries (the “Company”), headquartered in Burlington, North Carolina, is the second largest independent clinical laboratory company in the United States based on 2009 net revenues. Since the Company’s founding in 1971, it has grown into a... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Friday, April 19, 8:41 AM More on LabCorp's (LH) Q1 earnings: Special charges (including restructuring) which negatively affected Q1 results totaled $7.5M. FY2013 guidance reaffirmed at between $6.85-7.15. Revenue growth for the full year expected to be in the 2-3% range. Shares flat premarket. Comment! [Earnings, Healthcare]
- Friday, April 19, 6:54 AM Laboratory Corp (LH): Q1 EPS of $1.74 misses by $0.03. Revenue of $1.44B misses by $0.01B. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Friday, April 19, 12:05 AM Notable earnings before Friday’s open: BHI, COL, FHN, FNFG, GE, GPC, HON, IPG, KMB, KSU, LH, MAN, MCD, NPBC, SAP, SLB, STI, STT, TCB, TNP, UA Comment! [Earnings]
- Thursday, April 18, 5:30 PM Notable earnings before Friday’s open: BHI, COL, FHN, FNFG, GE, GPC, HON, IPG, KMB, KSU, LH, MAN, MCD, NPBC, SAP, SLB, STI, STT, TCB, TNP, UA Comment! [Earnings]
- Friday, April 12, 12:49 PM Lab Corp. (LH -1.8%) gives back yesterdays gains after being downgraded at WallachBeth Capital to Hold today on valuation. The stock was upgraded yesterday by Goldman, along with Quest Diagnostics (DGX -1.5%), on the sector's improving fundamentals. DGX appears to be giving back a little of the previous session's gain in sympathy as well. Comment! [Healthcare, On the Move]
- Thursday, April 11, 10:03 AM Goldman upgrades the Life Sciences Tools & Diagnostics sector to Attractive, but some individual names suffered as Mettler Toledo (MTD -2%) and Sigma-Aldrich (SIAL -1.1%) catch downgrades to Neutral from Buy. SIAL has "few levers to drive EBIT [as] long-term organic growth guidance of 4-6% is too high." Quest Diagnostics (DGX +3.5%) and LabCorp (LH +2%) are upgraded to Buy and Neutral respectively on the former's "untapped capital allocation potential and margin expansion" and the latter's ability to manage pricing pressure. Comment! [On the Move]
- Monday, April 1, 10:26 AM LabCorp (LH +0.3%) says that its subsidiary LabCorp Clinical Trials has been selected as a preferred provider for full-service global central laboratory services and biomarker testing by Bristol-Myers Squibb (BMY -0.2%). Under the terms of the five-year agreement, LH's global central lab, biomarker and specialty testing capabilities will support various early and late-stage clinical development programs for the drug giant. Comment! [Healthcare]
-
Sunday, March 10, 5:24 AM
Starbucks (SBUX), Time Warner (TWX) and LabCorp (LH) are among dozens of companies attempting to block decisions by the National Labor Relations Board following a court ruling in January that found President Barack Obama's board appointments to be unconstitutional. The companies, as well as some unions, have argued that the NLRB doesn't have the authority to make the decisions because of the ruling.
1 Comment [U.S. Economy, Top Stories, Consumer, Healthcare, Tech] - Friday, February 8, 6:58 AM Laboratory Corp. of America (LH): Q4 adj. EPS of $1.54 misses by $0.08. Revenue of $1.41B (+2.9% Y/Y) beats by $20M. (PR) Comment! [Earnings, Healthcare]
- Friday, February 8, 12:05 AM Notable earnings before Friday’s open: AOL, AXL, BPL, CBOE, ETR, GSM, LH, LPX, MCO, NBIX, PSEC, YRCW Comment! [Earnings]
- Thursday, February 7, 5:30 PM Notable earnings before Friday’s open: AOL, AXL, BPL, CBOE, ETR, GSM, LH, LPX, MCO, NBIX, PSEC, YRCW Comment! [Earnings]
- Wednesday, January 9, 3:40 PM Verastem (VSTM -0.2%) signs an agreement with Laboratory Corporation of America (LH +0.4%) to validate biomarkers for its lead focal adhesion kinase inhibitor VS-6063 in the development of an applicable companion diagnostic. The biomarkers will be used as subjects in its clinical studies in ovarian cancer and mesothelioma, including a potentially pivotal study to be initiated later this year. Comment! [Healthcare]
- Thursday, October 18, 2012, 9:46 AM More on LabCorp (LH -2.1%) Q3: net profit +10% to $148M, testing volumes +1.4%, revenue per requisition -0.3%. Narrows FY EPS guidance to $6.88-$6.93 on 2.5% revenue growth vs. prior forecast of $6.80-$7 and 2%-3%. Consensus is for EPS of $6.96. Comment! [Earnings, Healthcare]
- Thursday, October 18, 2012, 6:48 AM Laboratory Corp (LH): Q3 EPS of $1.76 beats by $0.02. Revenue of $1.42B misses by $20M. Comment! [Earnings, Healthcare]
- Thursday, October 18, 2012, 12:05 AM Notable earnings before Thursday’s open: BAX, BBT, BSX, BX, CY, DHR, DO, FCS, FITB, GPC, HBAN, KEY, LH, LUV, MS, NOK, NUE, PII, PM, PPG, SVU, TRV, UNP, USG, VZ Comment! [Earnings]
- Wednesday, October 17, 2012, 5:30 PM Notable earnings before Thursday’s open: BAX, BBT, BSX, BX, CY, DHR, DO, FCS, FITB, GPC, HBAN, KEY, LH, LUV, MS, NOK, NUE, PII, PM, PPG, SVU, TRV, UNP, USG, VZ 2 Comments [Earnings]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.